EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen

BMEMat · 2026-09 · 4 (3)

DOI: 10.1002/bmm2.70062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMEMat, online erschienen am 20.01.2026. Verfasst von Shilong Zhao und 4 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells. However, its efficacy is substantially hindered by the immunosuppressive nature of the tumor immune microenvironment (TIME). Recently, ultrasound (US)‐responsive nanoplatforms have emerged as a promising strategy to precisely reprogram the TIME by leveraging unique ultrasonic properties for spatiotemporal regulation of the activities of tumor cells, immune cells, and non‐immune stromal cells. This review summarizes the recent progress in engineering US‐responsive nanoplatforms aimed at reprogramming various critical cell populations of TIME. We first discuss US‐responsive nanoplatform strategies that target key organelles in tumor cells, including mitochondria, lysosomes, endoplasmic reticulum, and nucleus, to induce immunogenic cell death and enhance therapeutic efficacy. We also present US‐responsive nanoplatforms that regulate immune cells, including T cells, dendritic cells, macrophages, and natural killer cells, to reprogram the TIME. Additionally, we highlight how US‐responsive nanoplatforms can target non‐immune stromal cells, such as cancer‐associated fibroblasts and tumor endothelial cells, to inhibit angiogenesis and reverse immunosuppressive barriers. Finally, we discuss challenges in clinical translation and provide insights for future directions of US‐responsive nanoplatforms to reprogram the TIME for enhanced cancer immunotherapy.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhao, S., Qu, R., Dai, Z., Jiang, X., & Zhen, X. (2026). Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy. BMEMat, 4(3). https://doi.org/10.1002/bmm2.70062

Vancouver

Zhao S, Qu R, Dai Z, Jiang X, Zhen X. Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy. BMEMat. 2026;4(3). doi:10.1002/bmm2.70062

BibTeX
@article{Zhao2026,
  author = {Zhao, Shilong and Qu, Rui and Dai, Zan and Jiang, Xiqun and Zhen, Xu},
  title = {Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy},
  journal = {BMEMat},
  year = {2026},
  volume = {4},
  number = {3},
  doi = {10.1002/bmm2.70062}
}
Kostenlos starten →